| 5/31/2024 | BKHY | Moody's snips Embecta
|
| 11/3/2023 | BKHY | Moody’s turns Embecta view to negative
|
| 8/15/2022 | BKBWHY | Embecta structures balance sheet to fund both organic growth and M&A
|
| 3/24/2022 | BKCVDDEMIGPV | Market Commentary: Yum! doubles; Novolex on deck; Ford at a premium; Owens & Minor gains
|
| 3/23/2022 | BKCVDDEMIGPV | Market Commentary: Junk primary revives; Ford active, Embecta sinks on new offering; Carnival losses mount
|
| 3/23/2022 | BKHY | S&P gives Embecta notes B+
|
| 1/31/2022 | BKCVDDEMIGPV | Market Commentary: Calendar builds; secondary firms; Bausch, Embecta improve
|
| 1/28/2022 | BKCVDDEMIGPV | Market Commentary: ION, Covis on hold; volatile junk market ends day up, week down; athenahealth struggles
|
| 1/27/2022 | BK | Market Commentary: Crocs, Embecta, Intelsat, Bausch Health, TaylorMade, athenahealth, Inspire Brands break
|
| 1/27/2022 | BK | Embecta cuts spread on $1.15 billion term loan to SOFR plus 300 bps
|
| 1/26/2022 | BK | Market Commentary: RelaDyne, AssuredPartners, Alight free to trade; athenahealth revised; Embecta accelerated
|
| 1/24/2022 | BKHY | S&P rates Embecta notes B+
|
| 1/18/2022 | BK | Market Commentary: Griffon tweaks deal; Vaco accelerates deadline; Embecta, Syniverse, Dessert reveal talk
|
| 1/18/2022 | BK | Embecta launches $1.15 billion term loan at SOFR plus 350-375 bps
|
| 1/14/2022 | BK | Market Commentary: Micro Focus, Maravai, Simply Good break; Tropicana, Liberty Tire accelerate deadlines
|
| 1/14/2022 | BKHY | Moody's assigns Embecta, loans Ba3
|
| 1/14/2022 | BKHY | S&P gives Embecta, loans B+
|
| 1/14/2022 | BK | Embecta to launch $1.65 billion credit facilities on Tuesday
|
